Erika Yorida
Papers
1
Total Citations
42
H-Index
1
About
Dr. Erika Yorida is a leading figure in precision oncology, with her research centered on the development and clinical validation of next-generation sequencing assays for hereditary cancer syndromes. Her most significant contribution is the creation of a clinically validated diagnostic second-generation sequencing assay for detecting hereditary BRCA1 and BRCA2 mutations, a landmark study published in 2013 that has garnered 42 citations. This work directly addressed the critical need for accurate, high-throughput genetic testing in clinical settings, enabling more reliable identification of patients at risk for breast and ovarian cancers. By bridging the gap between advanced genomic technology and routine clinical diagnostics, Dr. Yorida's assay has become a foundational tool for genetic counseling and targeted therapy decisions. Her achievements underscore a commitment to translating complex genomic data into actionable patient care, making her a pivotal figure in the movement toward personalized medicine. For students and researchers, her work exemplifies how rigorous assay validation can transform genetic testing from a research tool into a standard-of-care practice.
Research Focus
Key Achievements
Top Papers
- 1